More Support for Omitting Lymph Node Biopsy in Low-Risk Early Breast Cancer

(MedPage Today) — SAN ANTONIO — Many patients with early breast cancer can safely skip sentinel lymph node biopsy (SLNB), results of a large Dutch study suggested.
After 5 years, the regional recurrence-free survival (RRFS) rate was 96.6…

Source link : https://www.medpagetoday.com/meetingcoverage/sabcs/118992

Author :

Publish date : 2025-12-12 19:06:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

More Support for Omitting Lymph Node Biopsy in Low-Risk Early Breast Cancer

What Trump’s Cognitive Tests Can — and Can’t — Reveal

Lowering FDA’s Drug-Approval Standards Is a Lose-Lose

Related Posts

The King’s Cancer Speech; Multiple Studies Retracted; Mass Sperm Donor Had TP53 Gene

Lowering FDA’s Drug-Approval Standards Is a Lose-Lose

What Trump’s Cognitive Tests Can — and Can’t — Reveal

Mounjaro Cleared for Type 2 Diabetes in EU Children

Novel Therapies in IgA Nephropathy Bring New Options, and New Questions

Targeted Therapy Nears EU Approval for Obstructive HCM

The King’s Cancer Speech; Multiple Studies Retracted; Mass Sperm Donor Had TP53 Gene

Lowering FDA’s Drug-Approval Standards Is a Lose-Lose

More Support for Omitting Lymph Node Biopsy in Low-Risk Early Breast Cancer

What Trump’s Cognitive Tests Can — and Can’t — Reveal

Mounjaro Cleared for Type 2 Diabetes in EU Children

Novel Therapies in IgA Nephropathy Bring New Options, and New Questions

Targeted Therapy Nears EU Approval for Obstructive HCM

Pre-Op MRI Shows ‘No Clinical Benefit’ in Early Breast Cancer

Categories

Archives